Public approval? Government regulations? Who needs 'em when you can use a global trade agreement to do an end run?
If you thought recent news stories claiming
that Monsanto has given up on trying to sell its genetically engineered
seeds in Europe sounded too good to be true, you were right. Far from
giving up, the biotech industry is now looking to a new trade pact
between the EU and the U.S. that could blow the European market wide
open for genetically modified organisms (GMOs). TheTransatlantic Trade and Investment Partnership (TTIP) calls for the removal of "unnecessary regulatory barriers" to trade. Among those barriers are restrictions on GMOs. Here's what Sen. Ron Wyden (D-Ore.) had to say about the deal:
"US seed companies
that for a decade have been struggling to break the deadlock over the
authorization for the cultivation of their [GM] seeds now will be
presented with the ultimate opportunity to change the entire process to
suit their needs."
The TTIP, and its
Pacific Rim counterpart, the Trans-Pacific Partnership (TPP), are being
negotiated in secret. No input from the public. No access by Congress,
despite requests from more than 140 Congress members to see drafts of
the negotiating texts. Who does have input? More than 600 corporations. And if President Obama gets his way, both deals will be "fast-tracked" with no debate.
Learn more here and here
TAKE ACTION: Tell President Obama and U.S. Trade Rep. Michael Froman: Trade Agreements Shouldn't Be Secret!